Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02580058
Brief Title: A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)

First Submitted : October 16, 2015
First Submitted that Met QC Criteria : October 16, 2015
First Posted : October 20, 2015 (Estimate)

Results First Submitted : September 9, 2019
Results First Submitted that Met QC Criteria : November 1, 2019
Results First Posted : November 19, 2019

Last Update Submitted that Met QC Criteria : March 4, 2021
Last Update Posted : March 8, 2021